Lung Cancer Treatment Breakthroughs Give Hope and the Chance for Patients to Appreciate the "Little Things" Their Lungs Do for Them
Los Angeles, CA, November 11, 2016 (Newswire.com) - Blowing out birthday candles, cheering for a favorite sports team, or inhaling the aroma of a fresh-baked pumpkin pie are just a few examples of the little things lung cancer patients and survivors are thankful for this November, during Lung Cancer Awareness Month.
Lung Cancer Foundation of America (LCFA) wants everyone to remember that “Life should take your breath away, not lung cancer.” Lung cancer strikes smokers, non-smokers, men, women, all races and all ages.
We are on the precipice of exciting new advancements in treating lung cancer. In the past two years, the Food and Drug Administration (FDA) approved twice as many new therapies for lung cancer patients than in the last ten years!
Kim Norris, Lung Cancer Foundation of America President and Co-Founder
In honor of lung cancer awareness month, LCFA is launching the “Little Things” campaign #littlethingsLCFA and urging people to share on social media how grateful they are for the little things their lungs allow them to do. People can help LCFA fund life-saving research by joining the “Little Things” campaign, posting to Facebook, Twitter and Instagram.
Lung cancer is the leading cause of cancer death among ALL Americans, killing twice as many women as breast cancer. There is a misconception about lung cancer that there isn’t much hope following a diagnosis. New patients need to know they should ask for genomic testing to identify their tumor type. Depending on the type of tumor, there are a number of treatment options.
New treatments for patients include using targeted therapy to treat more than a dozen types of lung cancer tumors. In addition, immunotherapy helps your immune system attack and kill cancer cells, effectively exposing cancer cells so your body can destroy them. Lung cancer patients should also investigate whether they are eligible for treatment through groundbreaking clinical trials.
“We are on the precipice of exciting new advancements in treating lung cancer. In the past two years, the Food and Drug Administration (FDA) approved twice as many new therapies for lung cancer patients than in the last ten years! But this momentum can only continue with funding for research. Lung cancer research is still severely underfunded, especially considering it kills more than breast, colon and prostate cancer combined,” says Kim Norris, LCFA President and Co-Founder.
About Lung Cancer Foundation of America (LCFA)
LCFA’s mission is the dramatic improvement in survivorship of lung cancer patients.
Press Contact:
Diane Mulligan
dmulligan@mandccommunications.com
720.273.0927
Source: Lung Cancer Foundation of America
